Clinical Trials in Baltimore

Showing 7021-7040 of 23,476 trials

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer

NCT02592967

The purpose of this study is to determine the recommended Phase 2 dose (RP2D) of JNJ-64041757 a live attenuated double deleted (LADD) Listeria monocytogenes (bacteria in which two virulence genes, which encode molecules that help cause disease, have been removed) when administered intravenously to participants with advanced (Stage IIIb) or metastatic (Stage IV) NSCLC (adenocarcinoma).

Carcinoma, Non-Small-Cell Lung

Janssen Research & Development, LLC18 participantsStarted Dec 2015

Duarte, California, United States • Baltimore, Maryland, United States • Bethesda, Maryland, United States +6 more locations

COMPLETEDPhase 1/27.6 miles

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

NCT05496231

The main purpose of this study was to evaluate the safety and reactogenicity of GlaxoSmithKline Biologicals SA (GSK)'s investigational adjuvanted human papillomavirus (HPV) vaccine formulations.

Cervical Intraepithelial Neoplasia

GlaxoSmithKline1,080 participantsStarted Aug 2022

San Diego, California, United States • San Diego, California, United States • Wheat Ridge, Colorado, United States +65 more locations

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Find Trials by Condition in Baltimore

Juvenile Idiopathic Arthritis (JIA) Registry

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

The ShortCut™ Study Protocol

Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)

Management of Postoperative Pain After Cesarean Delivery Using Bridge Auricular Percutaneous Nerve Field Stimulator

Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

A Study of Acute Respiratory Infections in Global Outpatient Setting

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants